Abstract
Antiphospholipid antibodies (aPL) have been reported to occur in several conditions other than antiphospholipid syndrome, including infections. We herein report the case of a 21-year-old Japanese woman with Parvovirus B19 infection, who developed multiple pulmonary emboli associated with aPL, a lupus anticoagulant and IgM anticardiolipin antibody. Eight weeks later, antiphospholipid antibodies spontaneously disappeared and normal pulmonary flow was observed. Considering the high prevalence of Parvovirus B19 infection, we should be aware of thrombosis associated with transient aPL antibodies in this infectious disease.
This is a preview of subscription content, log in via an institution to check access.
References
Uthman IW, Gharavi AE (2002) Viral infections and antiphospholipid antibodies. Semin Arthritis Rheum 31:256–263
Lehmann HW, von Landenberg P, Modrow S (2003) Parvovirus B19 infection and autoimmune disease. Autoimmun Rev 2:218–223
Harada M, Fujisawa Y, Sakisaka S, Kawaguchi T, Taniguchi E, Sakamoto M, Sumie S, Sasatomi K, Koga H, Torimura T et al (2000) High prevalence of anticardiolipin antibodies in hepatitis C virus infection: lack of effects on thrombocytopenia and thrombotic complications. J Gastroenterol 35:272–277
Ordi-Ros J, Villarreal J, Monegal F, Sauleda S, Esteban I, Vilardell M (2000) Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: characterization in relation to antiphospholipid syndrome. Clin Diagn Lab Immunol 7:241–244
Gratacos E, Torres PJ, Vidal J, Font J, Antolin E, Cararach V, Fortuny A (1995) Prevalence and clinical significance of anticardiolipin antibodies in pregnancies complicated by parvovirus B19 infection. Prenat Diagn 15:1109–1113
Reitblat T, Drogenikov T, Sigalov I, Oren S, London D (2000) Transient anticardiolipin antibody syndrome in a patient with parvovirus B19 infection. Am J Med 109:512–513
Cabiedes J, Cabral AR, Alarcon-Segovia D (1995) Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with antiβ2-glycoprotein-I than with antiphospholipid antibodies. J Rheumatol 22:1899–1906
Hess EV (1998) Is there a phospholipid specificity of lupus anticoagulants (LAC) in patients with autoimmune and drug induced LAC? J Rheumatol 25:200–202
Oger E, Lernyer C, Dueymes M, Le Moigne E, Bressolette L, Escoffre M, Youinou P, Mottier D (1997) Association between IgM anticardiolipin antibodies and deep venous thrombosis in patients without systemic lupus erythematosus. Lupus 6:455–461
Galli M, Comfurius P, Barbui T, Zwaal RF, Bevers EM (1992) Anticoagulant activity of β2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies. Thromb Haemost 68:297–300
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Asano, Y., Sarukawa, M., Idezuki, T. et al. Multiple small pulmonary emboli associated with transient antiphospholipid syndrome in human Parvovirus B19 infection. Clin Rheumatol 25, 585–587 (2006). https://doi.org/10.1007/s10067-005-0032-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-005-0032-1